ReLife launches in the UK
Italian pharmaceutical company Menarini Group has launched Definisse threads, fillers and peels by ReLife in the UK.
Italian pharmaceutical company Menarini Group has launched Definisse threads, fillers and peels by ReLife in the UK.
Global pharmaceutical company Allergan, an AbbVie company, has entered an agreement with privately owned aesthetics company Luminera.
Medical aesthetic product manufacturer Croma-Pharma GmbH has partnered with China National Biotec Group Company (CNBG) to enter the Chinese market to supply the country with its hyaluronic acid filler Princess VOLUME, as well as other products in the company’s portfolio.
Pharmaceutical company Mesoestetic has launched the mesofiller periocular, a new cross-linked HA dermal filler.
Mr James Olding details how facial bones change over time and provides considerations for dermal filler treatment
A study has suggested that retrobulbar hyaluronidase injection is unlikely to alleviate vision loss caused by hyaluronic acid (HA) filler injections.
On July 4 and 5, UK and Ireland distributor of IBSA Italia, HA-Derma invited a group of UK and Ireland based practitioners to visit pharmaceutical company Altergon’s factory, where the company’s products are developed.
On April 18 and 19, international delegates were invited to Malta to attend an educational event hosted by IBSA Italia.
On March 11, more than 350 doctors, dentists and nurses tuned into the Anatomy of the Smile webinar hosted by Aesthetics Media in association with Galderma UK.
Aesthetic nurse prescriber Anna Baker discusses the practical considerations for non-surgical injectable augmentation of the chin